AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
Public ClinicalTrials.gov record NCT05089708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne vulgaris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks of treatment in facial acne participants
Study identification
- NCT ID
- NCT05089708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 21, 2021
- Primary completion
- Dec 14, 2022
- Completion
- Dec 14, 2022
- Last update posted
- Dec 19, 2023
2021 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site #8636 | Fountain Valley | California | 92708 | — |
| Galderma Investigational Site #8224 | Fremont | California | 94538 | — |
| Galderma Investigational Site #8358 | San Diego | California | 92108 | — |
| Galderma Investigational Site #9955 | San Diego | California | 92123 | — |
| Galderma Investigational Site #7012 | Lutz | Florida | 33549 | — |
| Galderma Investigational Site #8184 | Maitland | Florida | 32751 | — |
| Galderma Investigational Site #8764 | Tampa | Florida | 33613 | — |
| Galderma Investigational Site #9950 | Evansville | Indiana | 47714 | — |
| Galderma Investigational Site #9952 | Baton Rouge | Louisiana | 70808 | — |
| Galderma Investigational Site #8606 | New Orleans | Louisiana | 70115 | — |
| Galderma Investigational Site #8012 | Glenn Dale | Maryland | 20769 | — |
| Galderma Investigational Site #9948 | Hyattsville | Maryland | 20782 | — |
| Galderma Investigational Site #8554 | Detroit | Michigan | 48202 | — |
| Galderma Investigational Site #8108 | Las Vegas | Nevada | 89148 | — |
| Galderma Investigational Site #8620 | New York | New York | 10025 | — |
| Galderma Investigational Site #9956 | New York | New York | 10025 | — |
| Galderma Investigational Site #9949 | New York | New York | 10155 | — |
| Galderma Investigational Site #9953 | Tulsa | Oklahoma | 74133 | — |
| Galderma Investigational Site #8207 | Nashville | Tennessee | 37215 | — |
| Galderma Investigational Site #9920 | Arlington | Texas | 76011 | — |
| Galderma Investigational Site #8329 | San Antonio | Texas | 78229 | — |
| Galderma Investigational Site #8433 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05089708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2023 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05089708 live on ClinicalTrials.gov.